Tissue factor pathway inhibitor : TFPI. Sous-cutané : SC. Intra-veineux ,
Common femoral vein dimensions and hemodynamics including Valsalva response as a function of sex, age, and ethnicity in a population study, Journal of Vascular Surgery, vol.33, issue.5, pp.1050-1056, 2001. ,
DOI : 10.1067/mva.2001.113496
EPIDEMIOLOGY OF COAGULATION FACTORS, INHIBITORS AND ACTIVATION MARKERS: THE THIRD GLASGOW MONICA SURVEY I. ILLUSTRATIVE REFERENCE RANGES BY AGE, SEX AND HORMONE USE, British Journal of Haematology, vol.97, issue.4, pp.775-84, 1997. ,
DOI : 10.1046/j.1365-2141.1997.1222936.x
Fibrinogen and Factor VIII, but Not Factor VII, Are Associated With Measures of Subclinical Cardiovascular Disease in the Elderly : Results From the Cardiovascular Health Study, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.15, issue.9, pp.1269-79, 1995. ,
DOI : 10.1161/01.ATV.15.9.1269
Age-Dependent Effect on the Level of Factor IX, American Journal of Clinical Pathology, vol.99, issue.6, pp.687-695, 1993. ,
DOI : 10.1093/ajcp/99.6.687
Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study., Journal of Clinical Investigation, vol.80, issue.6, pp.1527-1561, 1987. ,
DOI : 10.1172/JCI113238
Subunit antigen and activity levels of blood coagulation factor XII1 in healthy individuals. Relation to sex, age, smoking, and hypertension, Arterioscler Thromb Vasc Bi01, vol.19, pp.20-32, 1999. ,
Influence of aging on the activity of the hemostatic system: prothrombin fragment 1 +2, thrombin-antithrombin III complexes and D-dimers in 80 healthy subjects with age ranging from 20 to 94 years, Nouv Rev Fr, vol.34, pp.43-49, 1992. ,
Hypercoagulability in centenarians: the paradox of successful aging, Blood, vol.85, pp.3144-3153, 1995. ,
Age, Functional Status, and Racial Differences in Plasma D-Dimer Levels in Community-Dwelling Elderly Persons, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol.163, issue.6, pp.649-657, 2000. ,
DOI : 10.1084/jem.163.6.1363
Relationship of Plasmin Generation to Cardiovascular Disease Risk Factors in Elderly Men and Women, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.19, issue.3, pp.499-504, 1999. ,
DOI : 10.1161/01.ATV.19.3.499
Protein C, antithrombin III and plasminogen: effect of age, sex and blood group, British Journal of Haematology, vol.70, issue.4, pp.798-803, 1994. ,
DOI : 10.1007/BF00278781
Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: Correlation with age and serum triglyceride concentrations, Journal of the American College of Cardiology, vol.9, issue.2, pp.263-271, 1987. ,
DOI : 10.1016/S0735-1097(87)80373-X
Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly, Cardiovascular Research, vol.66, issue.2, pp.276-85, 2005. ,
DOI : 10.1016/j.cardiores.2004.11.013
Assay of procarboxypeptidase U, a novel determinant of the fibrinolytic cascade, in human plasma, Clin Chem, vol.45, issue.40, pp.807-820, 1999. ,
A Population-Based Perspective of the Hospital Incidence and Case-Fatality Rates of Deep Vein Thrombosis and Pulmonary Embolism, Archives of Internal Medicine, vol.151, issue.5, pp.933-941, 1991. ,
DOI : 10.1001/archinte.1991.00400050081016
Recurrent Venous Thromboembolism After Deep Vein Thrombosis, Archives of Internal Medicine, vol.160, issue.6, pp.769-74, 2000. ,
DOI : 10.1001/archinte.160.6.769
URL : http://archinte.jamanetwork.com/data/journals/intemed/11960/ioi90010.pdf
Prevention of venous thromboembolism, Chest, vol.1, issue.1, pp.19-132, 2001. ,
Risk Factors for Deep Vein Thrombosis and Pulmonary Embolism, Archives of Internal Medicine, vol.160, issue.6, pp.809-824, 2000. ,
DOI : 10.1001/archinte.160.6.809
Severe Pulmonary Embolism Associated with Air Travel, New England Journal of Medicine, vol.345, issue.11, pp.779-83, 2001. ,
DOI : 10.1056/NEJMoa010378
Assessment of the Risk for Venous Thromboembolism Among Users of Hormone Replacement Therapy, Drugs & Aging, vol.14, issue.1, pp.55-61, 1999. ,
DOI : 10.2165/00002512-199914010-00004
Indicators of lifetime endogenous estrogen exposure and risk of venous thromboembolism, Journal of Thrombosis and Haemostasis, vol.85, issue.1, pp.7-8, 2006. ,
DOI : 10.1161/01.CIR.101.8.841
URL : https://hal.archives-ouvertes.fr/hal-00688975
Prothrombotic Mutations, Hormone Therapy, and Venous Thromboembolism Among Postmenopausal Women: Impact of the Route of Estrogen Administration, Circulation, vol.112, issue.22, pp.3495-500, 2005. ,
DOI : 10.1161/CIRCULATIONAHA.105.565556
Activation of blood coagulation in cancer: Trousseau's syndrome revisited, Blood, vol.62, issue.50, pp.14-17, 1983. ,
Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin III and by gel filtration, Thrombosis Research, vol.9, issue.6, pp.575-83, 1976. ,
DOI : 10.1016/0049-3848(76)90105-5
Pharmacologie des héparines de bas poids inoléculaire, Medeclne Thérapeutique, vol.2, issue.52, pp.395-402, 1996. ,
Production and chemical processing of iow molecular weight heparins, Semin Thromb Hemost, vol.25, pp.5-16, 1999. ,
Low molecular weight heparins, N Engl J Med, vol.337, pp.688-98, 1997. ,
A multicenter randomized double-blind study of enoxaparin compared with unfiactionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group, Thromb Haemost, vol.76, pp.529-563, 1996. ,
Study to compare the efficacy and safety of the LMWH enoxaparin and standard heparin in the prevention of thromboembolic events in medical patients with cardiopulmonary diseases, Ann Hematol, vol.76, 1998. ,
The venous thrombotic risk in non-surgical patients: epidemiological data and efficacyJsafety profile of a low-molecular-weight heparin (enoxaparin). The Prime Study Group, Haemostasis, vol.26, issue.2, pp.49-56, 1996. ,
Prevention of venous thromboembolism in interna1 medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials, Thromb Haemost, vol.83, pp.14-23, 2000. ,
Prophylactic Anticoagulation for Venous Thromboembolic Disease in Geriatric Patients, Journal of the American Geriatrics Society, vol.31, issue.(S, pp.1472-1480, 2003. ,
DOI : 10.1161/01.STR.31.11.2563
Prevention of Venous Thromboembolism, Chest, vol.126, issue.3, pp.338-400, 2004. ,
DOI : 10.1378/chest.126.3_suppl.338S
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecularweight heparin, danaparoid, hirudin and related compounds, and argatroban, Arch Pathol Lab Med, vol.122, pp.799-807, 1998. ,
Limitations of the chronometric assays to determine plasma antifactor Xa activity during low molecular weight heparin therapy, Nouv Rev F r, vol.33, issue.64, pp.287-91, 1991. ,
Identification of risk factors for bleeding during treatment of acute venous thromboembolism with heparin or low molecular weight heparin, Blood, vol.78, issue.65, pp.2337-2380, 1991. ,
Chronic renal insufficiency. A permanent public health problem, Bull Acad Nat1 Med, vol.183, pp.1-1, 1999. ,
Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO), Kidney International, vol.67, issue.6, pp.2089-100, 2005. ,
DOI : 10.1111/j.1523-1755.2005.00365.x
The Incidence of End-Stage Renal Disease Is Increasing Faster than the Prevalence of Chronic Renal Insufficiency, Annals of Internal Medicine, vol.141, issue.2, pp.95-101, 2004. ,
DOI : 10.7326/0003-4819-141-2-200407200-00007
Impact of nephrology referral on early and midterm outcomes in ESRD: EPid??miologie de l???Insuffisance REnale chronique terminale en Lorraine (EPIREL): results of a 2-year, prospective, community-based study, American Journal of Kidney Diseases, vol.42, issue.3, pp.474-85, 2003. ,
DOI : 10.1016/S0272-6386(03)00805-9
Structural-fünctional correlations in renal disease. II. The correlations, Hum Pathol, vol.1, issue.71, pp.63-64, 1970. ,
Diseases of the kidney and urinary tract In: The kidney: structure and functionin health and disease, pp.836-887 ,
Measurment of the filtration rate In: The kidney: structure and function in health and disease, pp.39-62 ,
Performance of the Modification of Diet in Renal Disease and Cockcroft-Gault Equations in the Estimation of GFR in Health and in Chronic Kidney Disease, Journal of the American Society of Nephrology, vol.16, issue.2, pp.459-66, 2005. ,
DOI : 10.1681/ASN.2004060447
How to improve estimation of renal fünction in the elderly?, Rev Prat, vol.55, issue.76, pp.2223-2232, 2005. ,
Estimation of Renal Function in Subjects With Normal Serum Creatinine Levels: Influence of Age and Body Mass Index, American Journal of Kidney Diseases, vol.46, issue.2, pp.233-274, 2005. ,
DOI : 10.1053/j.ajkd.2005.05.011
Prevalence of Low Glomerular Filtration Rate in Nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III), Journal of the American Society of Nephrology, vol.13, issue.5, pp.1-3, 2002. ,
DOI : 10.1097/01.ASN.0000013291.78621.26
Effect of End-Stage Renal Disease on the Quality of Life of Older Patients, Journal of the American Geriatrics Society, vol.341, issue.Suppl 3, pp.229-262, 2003. ,
DOI : 10.1016/0140-6736(93)93003-J
Surveillance d???un traitement par la tinzaparine ?? dose curative pendant dix jours chez le sujet ??g??, La Revue de M??decine Interne, vol.22, issue.2, pp.120-126, 2001. ,
DOI : 10.1016/S0248-8663(00)00301-5
Safety profile of tinzaparin administered once daily at a standard curative dose in two hundred very elderly patients, Drug Saf, vol.25, pp.725-758, 2002. ,
Elderly patients treated with tinzaparin (Innohep) administered once daily (1 75 anti- Xa IU/kg): anti-Xa and anti-IIa activities over 10 days, Thromb Haemost, vol.84, pp.800-804, 2000. ,
Aging and venous thromboembolism influence the pharrnacodynamics of the antifactor Xa and anti-thrombin activities of a low molecular weight heparin (nadroparin), Thromb Haemost, vol.79, pp.1-162, 1998. ,
Efficacy and Safety of Fixed Low-Dose Dalteparin in Preventing Venous Thromboembolism Among Obese or Elderly Hospitalized Patients, Archives of Internal Medicine, vol.165, issue.3, pp.6534-6535, 2005. ,
DOI : 10.1001/archinte.165.3.341
URL : https://hal.archives-ouvertes.fr/hal-00427868
Reactive thrombocytosis at risk for thrombosis, Paris), vol.58, pp.508-519, 2000. ,
Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count, Jlntern Med, vol.1245, pp.999295-300 ,
1 Diagnosis and classification of erythrocytoses and thrombocytoses, Bailli??re's Clinical Haematology, vol.11, issue.4, pp.695-720, 1998. ,
DOI : 10.1016/S0950-3536(98)80035-8
Serum Albumin Level and Physical Disability as Predictors of Mortality in Older Persons, JAMA: The Journal of the American Medical Association, vol.272, issue.13, pp.1036-1078, 1994. ,
DOI : 10.1001/jama.1994.03520130074036
Cause-specific mortality in old age in relation to body mass index in middle age and in old age: follow-up of the Whitehall cohort of male civil servants, International Journal of Epidemiology, vol.35, issue.1, pp.169-78, 2006. ,
DOI : 10.7326/0003-4819-119-7_Part_2-199310011-00025
Correlation of plasma coagulation parameters with treatment, patients characteristics and outcome in the MEDENOX trial (abstract P2306), Thromb Haemost, vol.200, issue.1 ,